The 4th PAT & Real Time Quality Summit is the leading industry-specific forum for Process Analytical Technology (PAT) professionals in the biotech and pharmaceutical sectors. Taking place at a pivotal time, with the recent release of USP General Chapter <1037> and anticipated FDA guidelines on PAT due in July 2025, this summit is tailored to help organizations stay ahead of regulatory shifts and technological advancements.

Bringing together over 80+ PAT experts from leading pharmaceutical companies, biotechs, and CDMOs, the summit will address critical challenges such as high investment costs, integration with legacy systems, and data management. Through real-world case studies, panel discussions, and strategic roadmaps, you will explore how PAT is rapidly advancing in areas like biopharmaceuticals, personalized medicine, and complex therapies.

Join your peers this September to:

• Benchmarking strategies with top industry leaders and exploring cutting-edge technologies.
• Overcoming tech transfer challenges for small molecules and complex therapies.
• Understanding new FDA guidelines and aligning with GMP compliance.
• Demonstrating ROI and gaining executive buy-in through improved efficiency and reduced batch failures.
• Real-Time Release Testing, enabling faster timelines while maintaining high quality standards.

You are guaranteed to leave with actionable insights into PAT integration across the drug development lifecycle—from regulatory updates to real-time release strategies—ensuring smoother approvals, improved manufacturing processes, and enhanced product consistency.

With speakers from renowned organizations such as AstraZeneca, GlaxoSmithKline, and Pfizer, this summit provides an invaluable platform to exchange ideas, form collaborations, and successfully navigate the future of PAT in pharma and biopharma.

Don’t miss this opportunity to connect with the brightest minds in PAT and help shape the next generation of pharma manufacturing.